The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment versus SP randomized PII trial (XParTS II).
 
Michiya Kobayashi
No Relationships to Disclose
 
Akira Tsuburaya
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; TERUMO; Tsumura & Co.; Yakult Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Pharmaceutical
 
Junji Kawada
No Relationships to Disclose
 
Tsutomu Namikawa
No Relationships to Disclose
 
Ryoji Fukushima
No Relationships to Disclose
 
Hiroshi Kojima
No Relationships to Disclose
 
Kazuaki Tanabe
No Relationships to Disclose
 
Kazuya Yamaguchi
No Relationships to Disclose
 
Shigefumi Yoshino
No Relationships to Disclose
 
Masazumi Takahashi
No Relationships to Disclose
 
Naoki Hirabayashi
No Relationships to Disclose
 
Seiji Sato
No Relationships to Disclose
 
Hiroshi Nemoto
No Relationships to Disclose
 
Yasushi Rino
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Abbott Biotherapeutics; Chugai Pharma; Covidien; Johnson & Johnson; Kaken Pharmaceutical; Lilly; Ono Pharmaceutical; Secom Medical System; Taiho Pharmaceutical
Consulting or Advisory Role - Novartis
Research Funding - Chugai Pharma; Daiichi Sankyo; Nippon Kayaku; Ono Pharmaceutical; Yakult Pharmaceutical
 
Junta Nakajima
No Relationships to Disclose
 
Satoshi Morita
Honoraria - Chugai Pharma
Consulting or Advisory Role - Chugai Pharma
 
Junichi Sakamoto
No Relationships to Disclose